SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-17-019383
Filing Date
2017-05-10
Accepted
2017-05-10 16:36:45
Documents
44
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10q.htm 10-Q 437623
2 EXHIBIT 31 ex31.htm EX-31 12041
3 EXHIBIT 32 ex32.htm EX-32 5570
  Complete submission text file 0001140361-17-019383.txt   3101256

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT bstc-20170331.xml EX-101.INS 514027
5 XBRL TAXONOMY EXTENSION SCHEMA bstc-20170331.xsd EX-101.SCH 30711
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bstc-20170331_cal.xml EX-101.CAL 38697
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bstc-20170331_def.xml EX-101.DEF 119897
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE bstc-20170331_lab.xml EX-101.LAB 448443
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bstc-20170331_pre.xml EX-101.PRE 245540
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Filer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34236 | Film No.: 17830954
SIC: 2834 Pharmaceutical Preparations